| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |